Annovis – Headlands Research EMA

Enrolling Now

Study Information

Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants with Early Alzheimer’s Disease

Apply to Participate

If you are interested in participating in this study, please complete the following preliminary qualification form.

We will follow-up with you after we have received your submission.

"*" indicates required fields

Instagram

This field is for validation purposes and should be left unchanged.

Name*

First Middle Last

Phone*

E-mail*

What would you like to talk about?

I agree to Headlands Research's Privacy Policy.*

Yes

I agree to receive email and automated text messages. Msg & data rates may apply.*

Yes

This field is hidden when viewing the form